Novel flavonoids with antiproliferative activities against breast cancer cells

Journal of Medicinal Chemistry

Volumn 54, Issue 13, 2011, Pages 4339-4349

  Yao, Nianhuan ^a   Chen, Chao Yu ^a   Wu, Chun Yi ^a   Motonishi, Kiyomi ^a   Kung, Hsing Jien ^a,b   Lam, Kit S ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; ELONGATION FACTOR 2; ELONGATION FACTOR 2A; FLAVONOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CELL; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CYTOTOXICITY; DNA SEQUENCE; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; GENE EXPRESSION; IC 50; MOUSE; NONHUMAN; PHAGE DISPLAY; PROTEIN TARGETING; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; BACTERIOPHAGE T7; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLAVONES; HUMANS; IMIDAZOLES; NEOPLASMS, HORMONE-DEPENDENT; PEPTIDE ELONGATION FACTOR 1; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEOME; RECEPTORS, ESTROGEN; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE;

EID: 79960182468     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101440r     Document Type: Article

References (30)

1. Albrand, G.; Terret, C. Early breast cancer in the elderly: Assessment and management considerations Drugs Aging 2008, 25, 35-45
2. Baumann, C. K.; Castiglione-Gertsch, M. Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer Drugs 2007, 67, 2335-2353 (Pubitemid 350071046)
3. Coley, H. M. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer Cancer Treat. Rev. 2008, 34, 378-390
4. Rabaglio, M.; Aebi, S.; Castiglione-Gertsch, M. Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference Lancet Oncol. 2007, 8, 940-9 (Pubitemid 47488069)
5. Kolb, V. M. Biomimicry as a basis for drug discovery Prog. Drug Res. 1998, 51, 185-217 (Pubitemid 28511544)
6. Grabley, S.; Thiericke, R. Bioactive agents from natural sources: trends in discovery and application Adv. Biochem. Eng. Biotechnol. 1999, 64, 101-154
7. Vuorelaa, P.; Leinonenb, M.; Saikkuc, P.; Tammelaa, P.; Rauhad, J. P.; Wennberge, T.; Vuorela, H. Natural products in the process of finding new drug candidates Curr. Med. Chem. 2004, 11, 1375-1389 (Pubitemid 38735784)
8. Di Carlo, G.; Mascolo, N.; Izzo, A. A.; Capasso, F. Flavonoids: Old and new aspects of a class of natural therapeutic drugs Life Sci. 1999, 65, 337-353 (Pubitemid 29325278)
9. Jankun, J.; Selman, S. H.; Swiercz, R.; Skrzypczak-Jankun, E. Why drinking green tea could prevent cancer Nature 1997, 387, 561 (Pubitemid 27248750)
10. Birt, D. F.; Hendrich, S.; Wang, W. Dietary agents in cancer prevention: Flavonoids and isoflavonoids Pharmacol Ther 2001, 90, 157-177 (Pubitemid 32913477)
11. Bauvois, B.; Puiffe, M. L.; Bongui, J. B.; Paillat, S.; Monneret, C.; Dauzonne, D. Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13 J. Med. Chem. 2003, 46, 3900-3913 (Pubitemid 37034139)
12. Menichincheri, M.; Ballinari, D.; Bargiotti, A.; Bonomini, L.; Ceccarelli, W.; D'Alessio, R.; Fretta, A.; Moll, J.; Polucci, P.; Soncini, C.; Tibolla, M.; Trosset, J. Y.; Vanotti, E. Catecholic flavonoids acting as telomerase inhibitors J. Med. Chem. 2004, 47, 6466-6475 (Pubitemid 39657308)
13. Monteiro, R.; Azevedo, I.; Calhau, C. Modulation of aromatase activity by diet polyphenolic compounds J. Agric. Food Chem. 2006, 54, 3535-3540 (Pubitemid 43844178)
14. Kubo, I.; Kinst-Hori, I.; Chaudhuri, S. K.; Kubo, Y.; Sanchez, Y.; Ogura, T. Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria Bioorg. Med. Chem. 2000, 8, 1749-1755 (Pubitemid 30427241)
15. Yao, N.; Song, A.; Wang, X.; Dixon, S.; Lam, K. S. Synthesis of flavonoid analogues as scaffolds for natural product-based combinatorial libraries J. Comb. Chem. 2007, 9, 668-676
16. Scott, J. K.; Smith, G. P. Searching for peptide ligands with an epitope library Science 1990, 249, 386-390
17. Ballinger, M. D.; Shyamala, V.; Forrest, L. D.; Deuter-Reinhard, M.; Doyle, L. V.; Wang, J. X.; Panganiban-Lustan, L.; Stratton, J. R.; Apell, G.; Winter, J. A.; Doyle, M. V.; Rosenberg, S.; Kavanaugh, W. M. Semirational design of a potent, artificial agonist of fibroblast growth factor receptors Nat. Biotechnol. 1999, 17, 1199-1204
18. Zozulya, S.; Lioubin, M.; Hill, R. J.; Abram, C.; Gishizky, M. L. Mapping signal transduction pathways by phage display Nat. Biotechnol. 1999, 17, 1193-1198
19. Piggott, A. M.; Karuso, P. Rapid identification of a protein binding partner for the marine natural product kahalalide F by using reverse chemical proteomics ChemBioChem 2008, 9, 524-530
20. Yu, X.; Zhao, P.; Zhang, W.; Zhang, L.; Zhang, Y. Screening of phage displayed human liver cDNA library against dexamethasone J. Pharm. Biomed. Anal. 2007, 45, 701-705 (Pubitemid 350087565)
21. Jin, Y.; Yu, J.; Yu, Y. G. Identification of hNopp140 as a binding partner for doxorubicin with a phage display cloning method Chem. Biol. 2002, 9, 157-162 (Pubitemid 34196653)
22. Lam, K. S.; Lebl, M.; Krchnak, V. The "one-bead-one-compound" combinatorial library method Chem. Rev. 1997, 97, 411-448
23. Knudsen, SM, F. J.; Clark, B. F.; Leffers, H. Tissue-dependent variation in the expression of elongation factor-1 alpha isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation-factor 1 alpha Eur. J. Biochem. 1993, 215, 549-554 (Pubitemid 23246823)
24. Lamberti, A.; Caraglia, M.; Longo, O.; Marra, M.; Abbruzzese, A.; Arcari, P. The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article Amino Acids 2004, 26, 443-448 (Pubitemid 39093149)
25. Anand, N.; Murthy, S.; Amann, G.; Wernick, M.; Porter, L. A.; Cukier, I. H.; Collins, C.; Gray, J. W.; Diebold, J.; Demetrick, D. J.; Lee, J. M. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer Nat. Genet. 2002, 31, 301-305
26. Tomlinson, V. A.; Newbery, H. J.; Wray, N. R.; Jackson, J.; Larionov, A.; Miller, W. R.; Dixon, J. M.; Abbott, C. M. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours BMC Cancer 2005, 5, 113
27. Lee, J. The role of protein elongation factor eEF1A2 in ovarian cancer Reprod. Biol. Endocrinol. 2003, 1, 69
28. Li, R, W. H.; Bekele, B. N.; Yin, Z; Caraway, N. P.; Katz, R. L. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach Oncogene 2005, 25, 2628-2635
29. Amiri, A.; Noei, F.; Jeganathan, S.; Kulkarni, G.; Pinke, D. E.; Lee, J. M. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration Oncogene 2007, 26, 3027-3040 (Pubitemid 46733638)
30. Bunai, F.; Ando, K.; Ueno, H.; Numata, O. Tetrahymena eukaryotic translation elongation factor 1A (eEF1A) bundles filamentous actin through dimer formation J Biochem 2006, 140, 393-399 (Pubitemid 44703157)